Tirzepatide 12.5mg

Product description: 12.5mg Tirzepatide disposable pen

Dual GLP-1/GIP receptor agonist that has demonstrated extraordinary efficacy in clinical weight management trials. Tirzepatide simultaneously activates two key incretin pathways – GLP-1 and GIP – producing superior appetite suppression, enhanced insulin sensitivity, and accelerated fat loss.

This 12.5mg weekly dose is designed as an advanced dose, allowing to gradually progress to a dosage that suits them and find their optimal therapeutic level. Users should have already spent some time on a lower dose to test tolerance.

Begin with a low dose (typically 2.5mg per week) and increase by 2.5mg every 4 weeks as tolerated. Mild nausea may occur initially but typically resolves within 1–2 weeks.

All Disposable pen kits include:

• 1 X Disposable pen, Pre-filled with 4 Doses of 12.5 mg weekly Tirzepatide (total in cartridge 50mg)
• 6 X disposable 32G Injection tips
• 6 X Alcohol Wipes
• 1 X Users guide

Store refrigerated between 2–8°C and use within the recommended 6 weeks timeframe.